Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2020

Jun 10, 2020

34491_dirs_2020-06-10_821af7b1-7b81-4708-8fe5-d75477255a9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2020-06-08

Reporting Person: ANSARI ABID (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-08 Employee Stock Option (Right to Buy) $8.21 A 112141 Acquired 2030-06-07 Common Stock (112141) Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.